Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |